Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor
暂无分享,去创建一个
George H. Thomas | Julie De Backer | Paul Coucke | Anne De Paepe | Duke E. Cameron | Bart Loeys | Reed E. Pyeritz | Bert Callewaert | P. Byers | D. Milewicz | H. Dietz | R. Pyeritz | A. Roberts | A. De Paepe | A. Paepe | B. Loeys | F. Faravelli | B. Callewaert | P. Coucke | U. Schwarze | G. Thomas | Dianna M. Milewicz | Harry C. Dietz | J. De Backer | A. Braverman | Gretchen L. Oswald | Sylvie Manouvrier | D. Cameron | Tammy M. Holm | H. Pannu | S. Symoens | Hariyadarshi Pannu | Ulrike Schwarze | Peter H. Byers | Sofie Symoens | Amy E. Roberts | Francesca Faravelli | M. Alba Greco | Alan C. Braverman | J. Backer | S. Manouvrier | M. Greco
[1] N. Kouchoukos,et al. Life expectancy in the Marfan syndrome. , 1995, The American journal of cardiology.
[2] Yusuke Nakamura,et al. Heterozygous TGFBR2 mutations in Marfan syndrome , 2004, Nature Genetics.
[3] D. Judge,et al. Marfan's syndrome , 2005, The Lancet.
[4] Wolfram Kress,et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.
[5] N. Lindor,et al. From the Southern Association for Vascular Surgery The spectrum , management and clinical outcome of Ehlers-Danlos syndrome type IV : A 30-year experience , 2005 .
[6] S. Scherer,et al. Mapping a Locus for Familial Thoracic Aortic Aneurysms and Dissections (TAAD2) to 3p24–25 , 2003, Circulation.
[7] S. Shete,et al. Mutations in Transforming Growth Factor-&bgr; Receptor Type II Cause Familial Thoracic Aortic Aneurysms and Dissections , 2005, Circulation.
[8] U. Schwarze,et al. Splicing defects in the COL3A1 gene: marked preference for 5' (donor) spice-site mutations in patients with exon-skipping mutations and Ehlers-Danlos syndrome type IV. , 1997, American journal of human genetics.
[9] C. Weghorst,et al. Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck. , 1997, Carcinogenesis.
[10] R. Hesketh,et al. Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer. , 2001, Cancer research.
[11] P. Byers,et al. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. , 2000, The New England journal of medicine.
[12] E. Arbustini,et al. Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects , 2006, European Journal of Human Genetics.
[13] Marc K. Halushka,et al. Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.